Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
PUT
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$42B
| $3.53M | ﹤0.01% |
75,200
+47,000
| +167% | +$2.26M |
|
|
MOMO
4127
Hello Group
MOMO
$850M
| $3.53M | ﹤0.01% |
505,574
-18,794
| -4% | -$173K |
|
4128
CALL
Alamos Gold
AGI
$14B
| $3.52M | ﹤0.01% |
312,200
+78,600
| +34% | +$946K |
|
4129
Vanguard S&P 500 ETF
VOO
$1.04T
| $3.52M | ﹤0.01% |
8,975
-99,539
| -92% | -$40.7M |
|
4130
CONMED
CNMD
$1.51B
| $3.52M | ﹤0.01% |
34,927
-174,141
| -83% | -$20M |
|
4131
CALL
Deluxe
DLX
$1.1B
| $3.52M | ﹤0.01% |
186,400
+2,400
| +1% | +$46.6K |
|
4132
PUT
Viatris
VTRS
$18.6B
| $3.51M | ﹤0.01% |
356,200
-75,500
| -17% | -$786K |
|
4133
Macerich
MAC
$7.01B
| $3.51M | ﹤0.01% |
321,895
-16,474
| -5% | -$197K |
|
4134
CALL
Oshkosh
OSK
$9.44B
| $3.51M | ﹤0.01% |
36,800
-8,900
| -19% | -$863K |
|
4135
Mercer International
MERC
$31.6M
| $3.51M | ﹤0.01% |
409,266
+188,564
| +85% | +$1.63M |
|
4136
Cushman & Wakefield Ltd
CWK
$3.38B
| $3.51M | ﹤0.01% |
460,661
+385,118
| +510% | +$3.49M |
|
4137
PUT
Children's Place
PLCE
$54.3M
| $3.51M | ﹤0.01% |
129,800
+47,300
| +57% | +$1.28M |
|
4138
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.19B
| $3.51M | ﹤0.01% |
+23,343
| New | +$3.65M |
|
4139
Arch Capital
ACGL
$33.7B
| $3.51M | ﹤0.01% |
43,976
+42,500
| +2,879% | +$3.31M |
|
4140
PUT
Tradr 1.25X NVDA Bear Daily ETF
NVDS
$12.6M
| $3.5M | ﹤0.01% |
5,893
+4,340
| +279% | +$2.53M |
|
4141
PUT
Neurocrine Biosciences
NBIX
$15.5B
| $3.5M | ﹤0.01% |
31,100
+1,700
| +6% | +$179K |
|
4142
Alpha Metallurgical Resources
AMR
$2.11B
| $3.49M | ﹤0.01% |
13,447
+12,261
| +1,034% | +$2.39M |
|
4143
UiPath
PATH
$8.3B
| $3.49M | ﹤0.01% |
204,036
+182,783
| +860% | +$3.04M |
|
4144
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.59B
| $3.49M | ﹤0.01% |
28,896
+7,485
| +35% | +$929K |
|
|
AVNS
4145
DELISTED
Avanos Medical
AVNS
| $3.49M | ﹤0.01% |
172,459
-179,237
| -51% | -$4.06M |
|
4146
PUT
Array Technologies
ARRY
$778M
| $3.49M | ﹤0.01% |
157,100
-79,400
| -34% | -$1.72M |
|
|
JPS
4147
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
| $3.49M | ﹤0.01% |
564,923
+549,554
| +3,576% | +$3.49M |
|
4148
Weis Markets
WMK
$1.76B
| $3.48M | ﹤0.01% |
55,303
-46,155
| -45% | -$3.01M |
|
4149
PUT
America Movil
AMX
$70.3B
| $3.48M | ﹤0.01% |
201,000
+198,300
| +7,344% | +$3.88M |
|
4150
CALL
ProShares UltraPro Short Dow 30
SDOW
$186M
| $3.48M | ﹤0.01% |
33,325
+22,375
| +204% | +$2.11M |
|
Similar funds
Citadel Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Citadel Advisors opened 1,406 new positions and closed 1,460 in Q3 2023.
- Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.